These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta. Aguirre-Crespo F, Vergara-Galicia J, Villalobos-Molina R, Javier López-Guerrero J, Navarrete-Vázquez G, Estrada-Soto S. Life Sci; 2006 Aug 08; 79(11):1062-8. PubMed ID: 16630635 [Abstract] [Full Text] [Related]
5. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Liu CQ, Leung FP, Wong SL, Wong WT, Lau CW, Lu L, Yao X, Yao T, Huang Y. Biochem Pharmacol; 2009 Aug 15; 78(4):374-81. PubMed ID: 19409373 [Abstract] [Full Text] [Related]
6. The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione. Sarr M, Sar FB, Gueye L, Kane MO, Wele A, Diallo AS, Schini-Kerth V, Muller B. Cardiovasc J Afr; 2011 Aug 15; 22(1):7-13. PubMed ID: 21298199 [Abstract] [Full Text] [Related]
12. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta. Vetrovsky P, Boucher JL, Schott C, Beranova P, Chalupsky K, Callizot N, Muller B, Entlicher G, Mansuy D, Stoclet JC. J Pharmacol Exp Ther; 2002 Nov 15; 303(2):823-30. PubMed ID: 12388669 [Abstract] [Full Text] [Related]
13. Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats. Jiang F, Dusting GJ. Br J Pharmacol; 2001 Apr 15; 132(7):1558-64. PubMed ID: 11264250 [Abstract] [Full Text] [Related]
15. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid. Ajay M, Achike FI, Mustafa MR. Pharmacol Res; 2007 May 15; 55(5):385-91. PubMed ID: 17317209 [Abstract] [Full Text] [Related]
16. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Feelisch M, Kotsonis P, Siebe J, Clement B, Schmidt HH. Mol Pharmacol; 1999 Aug 15; 56(2):243-53. PubMed ID: 10419542 [Abstract] [Full Text] [Related]